- Approval Id
- 306443d8e05371cc
- Drug Name
- FUGACIN TABLET 200 MG
- Product Name
- FUGACIN TABLET 200 MG
- Approval Number
- SIN08409P
- Approval Date
- 1995-10-26
- Registrant
- ZYFAS PHARMA PTE LTD
- Licence Holder
- ZYFAS PHARMA PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>[DOSAGE AND ADMINISTRATION]</strong><br>
FUGACIN is generally given to adults orally in a daily dose of 1.5–3 tablets (300–600mg) divided into 2 to 3 times.<br>
Dosage may be adjusted according to causative organisms and severity of symptoms.<br>
<strong>Overdose: In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation.</strong></p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>[INDICATIONS]</strong><br>
The following infections caused by ofloxacin-susceptible Staphylococcus sp., Streptococcus pyogenes, hemolytic streptococci, enterococci, Streptococcus pneumoniae, peptostreptococcus sp., Escherichia coli, Citrobacter sp., Shigella sp., Klebsiella pneumoniae, Enterobacter sp., Serratia sp., Proteus sp., Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter sp., and Campylobacter sp.</p>
<ul>
<li>Folliculitis, furuncle, furunculosis, carbuncle, erysipelas, phlegmon, lymphangitis (lymphadenitis)</li>
<li>Felon, subcutaneous abscess, spiradenitis, acne conglobata, infectious atheroma, perianal abscess</li>
<li>Mastadenitis, superficial secondary infections after traumas, burns, surgery traumas</li>
<li>Pharyngolaryngitis, acute bronchitis, tonsillitis, chronic bronchitis, diffuse panbronchiolitis, bronchiectasis with infection, secondary infections of chronic respiratory diseases, pneumonia</li>
<li>Pyelonephritis, cystitis, prostatitis, epididymitis, gonococcal urethritis, non-gonococcal urethritis</li>
<li>Cholecystitis, cholangitis, bacillary dysentery, enteritis</li>
<li>Intrauterine infection, adnexitis, bartholinitis</li>
<li>Blepharitis, hordeolum, dacryocystitis, tarsadentitis, keratohelcosis</li>
<li>Otitis media, sinusitis</li>
</ul>
- Contraindications
- <ol>
<li>Contraindication<br>
Patients with a history of hypersensitivity to ofloxacin.</li>
<li>Careful administration<br>
<ol class="decimalparen">
<li>Patients with severe renal disorders</li>
<li>Patients with or with a history of convulsive diseases such as epilepsy.</li>
<li>Patients with a history of hypersensitivity to quinolones.</li>
<li>The elderly patients</li>
</ol>
</li>
</ol>
- Atc Code
- J01MA01
- Atc Item Name
- ofloxacin
- Pharma Manufacturer Name
- ZYFAS PHARMA PTE. LTD.
- Company Detail Path
- /organization/zyfas-pharma-pte-ltd
